A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency

Immun Inflamm Dis. 2023 Aug;11(8):e930. doi: 10.1002/iid3.930.

Abstract

Background: The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease resulting from loss-of-function mutations in ADA2, formerly named CECR1 (cat eye syndrome chromosome region, candidate 1) gene. Disease manifestations could be separated into three major phenotypes: inflammatory/vascular, immune dysregulatory, and hematologic; however, most patients presented with significant overlap between these three phenotype groups.

Case presentation: We present a case of DADA2 deficiency with disease onset at 3 years old, not recognized till the age of 18 with severe gastrointestinal vasculitis and recurrent episodes of neutropenia associated with a new CECR1 mutation.

Keywords: adenosine deaminase 2 deficiency; mutation; neutropenia.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Deaminase* / genetics
  • Intercellular Signaling Peptides and Proteins* / genetics
  • Mutation

Substances

  • Adenosine Deaminase
  • Intercellular Signaling Peptides and Proteins

Supplementary concepts

  • deficiency of adenosine deaminase 2
  • Severe combined immunodeficiency due to adenosine deaminase deficiency